| Victoria Reyes, MS SLP | |
|
D6 Calle Los Picachos, Colinas Metropolitanas, Guaynabo, PR 00969-5216 | |
| (787) 346-2069 | |
| Not Available |
| Full Name | Victoria Reyes |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | D6 Calle Los Picachos, Guaynabo, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295112795 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3054 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Victoria Reyes, MS SLP D6 Calle Los Picachos, Colinas Metropolitanas, Guaynabo, PR 00969-5216 Ph: (787) 346-2069 | Victoria Reyes, MS SLP D6 Calle Los Picachos, Colinas Metropolitanas, Guaynabo, PR 00969-5216 Ph: (787) 346-2069 |
News Archive
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
Business is good for fact-checkers. Various news organizations as well as FactCheck.org and PolitiFact.org, have weeded through the rhetoric on both sides of the health reform debate.
Depression and long-term stress have been demonstrated to cause changes in the brain which offer a partial explanation for depressive moods, apathy, memory difficulties and other symptoms commonly associated with depression.
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc. today announced the dosing of the first patient in the third phase 3 clinical trial of lubiprostone for the treatment of opioid-induced bowel dysfunction (OBD) in subjects with chronic, non-cancer pain, excluding those taking methadone. The primary endpoint is an overall responder rate based on the change from baseline in the reported frequency of spontaneous bowel movements (SBMs).
NeuroDerm, Ltd. announced today that patient enrollment has begun in a Phase 2a clinical study of ND0801, a new product for the treatment of Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD) in adults. ND0801, based on a new, proprietary combination with nicotinic actions, is being developed as a dermal patch and will be evaluated for the treatment of cognitive impairment in several disorders including Alzheimer's disease, schizophrenia and advanced Parkinson's disease, among others.
› Verified 3 days ago
Miss Vivian Sofia Hernandez, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Gaviota C-6 Tierralta 1, Guaynabo, PR 00969 Phone: 787-731-9619 | |
Wanda Ivette Figueroa, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Cond.plaza Real Caparra Carr.#2, Apt.503, Guaynabo, PR 00966 Phone: 787-600-3380 | |
Mrs. Maria Del Mar Rivera Echeandia, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Santa Maria Shopping Center Local A-13, Ave Lomas Verdes, Guaynabo, PR 00921 Phone: 787-380-5781 | |
Valeria F Caraballo Couret, M.S ., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 Carr 19 Apt G301, Guaynabo, PR 00966 Phone: 939-281-6230 | |
Niurka Mejias, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 498 Cond Caparra Chalets, Box 44, Guaynabo, PR 00966 Phone: 787-638-3759 | |
Mariangel Calderon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Ave Las Cumbres Ste 208, Guaynabo, PR 00969 Phone: 787-782-1058 | |
Ms. Migdalia Amara Perez, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Cond San Francisco Javier, 50, San Jose St, 1005, Guaynabo, PR 00969 Phone: 787-764-1750 |